{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:50:34Z","timestamp":1793242234786,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,5,19]]},"abstract":"\n Importance<\/jats:title>\n Acute sinusitis has the highest rate of antibiotic prescribing in adults younger than 65 years. There is no consensus regarding whether amoxicillin-clavulanate or amoxicillin should be first-line treatment for uncomplicated acute sinusitis in adults.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare the risk of treatment failure and adverse events between standard-dose amoxicillin-clavulanate vs standard-dose amoxicillin for acute sinusitis in adults.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n New-user, active comparator retrospective cohort study using a nationwide health care utilization database comparing amoxicillin-clavulanate vs amoxicillin for adults aged 18 to 64 years with outpatient acute sinusitis. Patients with a new acute sinusitis diagnosis between January 1, 2018, and December 1, 2023, were eligible. Statistical analysis was conducted between July and November 2025. Propensity score matching was used to help mitigate confounding.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Standard-dose amoxicillin-clavulanate (875 mg-125 mg twice daily) or standard-dose amoxicillin (875 mg twice daily or 500 mg 3 times daily).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was treatment failure, defined as the first occurrence of a new antibiotic dispensation (with or without an outpatient visit), emergency department or inpatient encounter for acute sinusitis, or inpatient encounter for a sinusitis complication assessed 1 to 14 days after treatment initiation. Antibiotic-associated adverse events and secondary infections were also assessed.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The full cohort included 521\u202f244 eligible patients. After propensity score matching, there were 234\u202f608 patients (117\u202f304 patients per group; 65.5% female; median [IQR] age, 43 [31-54] years). Treatment failure occurred in 3.1% of patients overall, with 0.03% requiring an emergency department or inpatient encounter. There was no observed difference in the risk of treatment failure between the amoxicillin-clavulanate vs amoxicillin groups (3.0% vs 3.1%; risk ratio [RR], 0.96 [95% CI, 0.92-1.01]), which was consistent across sensitivity analyses. There was no difference in antibiotic-associated adverse events (1.3% vs 1.2%; RR, 1.04 [95% CI, 0.97-1.12]). The risk of secondary infections was higher for amoxicillin-clavulanate vs amoxicillin, including yeast infections (1.1% vs 0.8%; RR, 1.40 [95% CI, 1.29-1.53]) and\n Clostridioides difficile<\/jats:italic>\n infections (0.04% vs 0.02%; RR, 2.14 [95% CI, 1.29-3.54]).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this observational study of patients aged 18 to 64 years with acute sinusitis treated in the outpatient setting with standard-dose amoxicillin-clavulanate or standard-dose amoxicillin, there was no observed difference in treatment failure. Amoxicillin-clavulanate was associated with a higher, albeit rare, risk of adverse events. These findings suggest standard-dose amoxicillin may be a preferred first-line treatment for adults with uncomplicated acute sinusitis.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2025.26902","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:30:19Z","timestamp":1776515419000},"page":"1694","source":"Crossref","is-referenced-by-count":6,"title":["Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults"],"prefix":"10.1001","volume":"335","author":[{"given":"Timothy J.","family":"Savage","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Butler","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, John T. Milliken Department of Medicine, Washington University School of Medicine, St Louis, Missouri"},{"name":"Department of Surgery, Public Health Sciences Division, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Kronman","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Pediatrics, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Durkin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, John T. Milliken Department of Medicine, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushama Kattinakere","family":"Sreedhara","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kabbani","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri A.","family":"Hicks","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"17","key":"joi250124r1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011.","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"joi250124r2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamainternmed.2018.0407","article-title":"Antibiotic therapy duration in US adults with sinusitis.","volume":"178","author":"King","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"6","key":"joi250124r3","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/lary.31227","article-title":"Trends and frequencies of antibiotic prescriptions for acute sinusitis outpatient visits in adults.","volume":"134","author":"Jin","year":"2024","journal-title":"Laryngoscope"},{"issue":"8","key":"joi250124r4","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"joi250124r5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599815572097","article-title":"Clinical practice guideline (update): adult sinusitis.","volume":"152","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"joi250124r6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/j.1875-9114.1984.tb03333.x","article-title":"Amoxicillin and potassium clavulanate: an antibiotic combination mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.","volume":"4","author":"Weber","year":"1984","journal-title":"Pharmacotherapy"},{"issue":"23","key":"joi250124r7","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1001\/jama.2017.18715","article-title":"Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections.","volume":"318","author":"Gerber","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"joi250124r9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv113","article-title":"Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection.","volume":"2","author":"Dantes","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"joi250124r10","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1001\/jama.2023.15503","article-title":"Treatment failure and adverse events after amoxicillin-clavulanate vs amoxicillin for pediatric acute sinusitis.","volume":"330","author":"Savage","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"joi250124r11","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1542\/peds.2013-1071","article-title":"Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years.","volume":"132","author":"Wald","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"joi250124r12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0022-3476(84)81018-5","article-title":"Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor.","volume":"104","author":"Wald","year":"1984","journal-title":"J Pediatr"},{"issue":"4","key":"joi250124r13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/0194599818815109","article-title":"The microbiology of complicated acute sinusitis among pediatric patients: a case series.","volume":"160","author":"Mulvey","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"joi250124r14","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1002\/lary.29564","article-title":"Microbiology of acute maxillary sinusitis in children.","volume":"131","author":"Sawada","year":"2021","journal-title":"Laryngoscope"},{"issue":"4","key":"joi250124r15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/jama.2023.10854","article-title":"Identifying children likely to benefit from antibiotics for acute sinusitis: a randomized clinical trial.","volume":"330","author":"Shaikh","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"joi250124r16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/00006454-198710000-00040","article-title":"Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media.","volume":"6","author":"Howie","year":"1987","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"joi250124r17","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12465","article-title":"Comparative effectiveness of amoxicillin versus amoxicillin-clavulanate among adults with acute sinusitis in emergency department and urgent care settings.","volume":"2","author":"Rovelsky","year":"2021","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"4","key":"joi250124r18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1542\/peds.107.4.619","article-title":"A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis.","volume":"107","author":"Garbutt","year":"2001","journal-title":"Pediatrics"},{"issue":"9","key":"joi250124r19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs.","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"3","key":"joi250124r20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/pds.5407","article-title":"Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators.","volume":"31","author":"Sendor","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"joi250124r21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/pds.5617","article-title":"Accuracy of identifying pediatric acute bacterial sinusitis diagnoses in outpatient claims data.","volume":"32","author":"Savage","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"joi250124r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.2713","article-title":"High-dose vs standard-dose amoxicillin plus clavulanate for adults with acute sinusitis: a randomized clinical trial.","volume":"4","author":"Gregory","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"joi250124r23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/fampra\/cmx118","article-title":"Informing antimicrobial stewardship: factors associated with inappropriate antimicrobial prescribing in primary care.","volume":"35","author":"Singer","year":"2018","journal-title":"Fam Pract"},{"issue":"3","key":"joi250124r24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/ice.2017.263","article-title":"Patient, provider, and practice characteristics associated with inappropriate antimicrobial prescribing in ambulatory practices.","volume":"39","author":"Schmidt","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"joi250124r25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1017\/ice.2021.476","article-title":"Using machine learning to examine drivers of inappropriate outpatient antibiotic prescribing in acute respiratory illnesses.","volume":"44","author":"King","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"joi250124r26","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx279","article-title":"Characteristics of primary care physicians associated with high outpatient antibiotic prescribing volume.","volume":"5","author":"Fleming-Dutra","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"joi250124r27","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models.","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"1","key":"joi250124r28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects.","volume":"70","author":"Rosenbaum","year":"1984","journal-title":"Biometrika"},{"issue":"6","key":"joi250124r29","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"7","key":"joi250124r30","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/jac\/dkw054","article-title":"Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis.","volume":"71","author":"Schr\u00f6der","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"joi250124r31","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/EDE.0000000000000886","article-title":"Erratum: high-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"29","author":"Wyss","year":"2018","journal-title":"Epidemiology"},{"issue":"4","key":"joi250124r32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"3","key":"joi250124r33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.e28","article-title":"Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America.","volume":"103","author":"Levine","year":"1999","journal-title":"Pediatrics"},{"issue":"7219","key":"joi250124r34","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/bmj.319.7219.1239","article-title":"Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8.","volume":"319","author":"Magee","year":"1999","journal-title":"BMJ"},{"issue":"3","key":"joi250124r35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.","volume":"96","author":"Austin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"joi250124r36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies.","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"3","key":"joi250124r37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cpt.329","article-title":"Transparency and reproducibility of observational cohort studies using large healthcare databases.","volume":"99","author":"Wang","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"joi250124r39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on P values: context, process, and purpose.","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"issue":"10","key":"joi250124r40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"joi250124r41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"7168","key":"joi250124r42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat.","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"issue":"12","key":"joi250124r43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41579-023-00936-9","article-title":"Antibiotic-induced collateral damage to the microbiota and associated infections.","volume":"21","author":"de Nies","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"joi250124r44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/lary.26671","article-title":"Emergency department use for acute rhinosinusitis: insurance dependent for children and adults.","volume":"128","author":"Bergmark","year":"2018","journal-title":"Laryngoscope"},{"issue":"4","key":"joi250124r45","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1542\/peds.2012-2500","article-title":"Racial differences in antibiotic prescribing by primary care pediatricians.","volume":"131","author":"Gerber","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"joi250124r46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2022.10952","article-title":"Changes in the relationship between income and life expectancy before and during the COVID-19 pandemic, California, 2015-2021.","volume":"328","author":"Schwandt","year":"2022","journal-title":"JAMA"},{"key":"joi250124r8","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Revised December 2019. Accessed December 29, 2025. https:\/\/www.cdc.gov\/antimicrobial-resistance\/media\/pdfs\/2019-ar-threats-report-508.pdf"},{"key":"joi250124r38","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2013. Accessed December 29, 2025. http:\/\/www.r-project.org"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2847972\/jama_savage_2026_oi_250124_1778177995.70642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:00:36Z","timestamp":1779202836000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2847972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":46,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,5,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.26902","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}